Active Substance: Human Plasma Proteins .
Overview
Welcome to Dwaey, specifically on OCTAPLAS LG page.
This medicine contains an important and useful components, as it consists of
Human Plasma Proteins
is available in the market in concentration
Levosalbutamol
Levosalbutamol (also known as levalbuterol) is a selective beta-2 adrenergic agonist used primarily in the management of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing bronchial muscles to alleviate symptoms such as wheezing and shortness of breath. While generally safe, there are several precautions to consider: - **Cardiovascular Issues**: Levosalbutamol can cause tachycardia, palpitations, and increased blood pressure, especially in patients with pre-existing cardiovascular conditions such as heart disease, hypertension, or arrhythmias. These effects are generally mild but should be monitored, particularly in elderly patients or those with significant heart conditions. - **Hypersensitivity Reactions**: As with other beta-agonists, some patients may experience allergic reactions, including rash, urticaria, or more severe responses like anaphylaxis. If any signs of an allergic reaction occur, the medication should be discontinued immediately. - **Paradoxical Bronchospasm**: A rare but serious side effect of beta-agonists, including levosalbutamol, is paradoxical bronchospasm, where the drug can cause a worsening of bronchoconstriction instead of relieving it. This should be considered if the patient experiences an acute worsening of symptoms after inhalation. - **Pregnancy and Breastfeeding**: Levosalbutamol is classified as a Category C drug during pregnancy. This means it should only be used if the potential benefit justifies the potential risk to the fetus. For breastfeeding mothers, it is not known if levosalbutamol passes into breast milk, so caution is recommended when using this drug during lactation. - **Diabetes**: Beta-agonists like levosalbutamol may increase blood glucose levels, and patients with diabetes or those at risk of hyperglycemia should monitor their blood sugar levels closely when using this medication. - **Thyroid Disorders**: Levosalbutamol should be used with caution in patients with hyperthyroidism, as beta-agonists can exacerbate symptoms like tachycardia or arrhythmias.
Levosalbutamol is used as a bronchodilator for the treatment and management of respiratory conditions such as asthma and COPD. It is indicated for: - **Asthma**: Levosalbutamol is commonly used for the acute relief of bronchospasm in asthma patients. It is preferred for patients who require selective beta-2 adrenergic stimulation with minimal beta-1 effects (such as tachycardia). It is often used as a quick-relief or "rescue" inhaler for asthma attacks. - **Chronic Obstructive Pulmonary Disease (COPD)**: Levosalbutamol is also used for the relief of bronchospasm and shortness of breath in patients with COPD, a condition that involves chronic obstruction of airflow in the lungs. - **Exercise-Induced Bronchospasm**: Levosalbutamol may be used before exercise to prevent exercise-induced bronchospasm in patients who are at risk for this condition. While it is not commonly used for off-label purposes, in some cases, levosalbutamol may be prescribed for other types of bronchospasm, or for management of wheezing associated with other conditions. However, these uses would require physician approval.
Levosalbutamol should be avoided in the following situations: - **Hypersensitivity**: Contraindicated in patients who have a known hypersensitivity to levosalbutamol or any other component of the formulation. Severe allergic reactions, including anaphylaxis, can occur in rare cases. - **Tachyarrhythmias**: Levosalbutamol should not be used in patients with a history of tachyarrhythmias or those experiencing severe tachycardia, as it may exacerbate these conditions by increasing heart rate. - **Monoamine Oxidase Inhibitors (MAOIs)**: Use of levosalbutamol in combination with MAO inhibitors or within two weeks of discontinuing an MAOI is contraindicated due to the risk of hypertensive crises, as both drugs may increase sympathetic nervous system activity. - **Severe Hypertension**: Levosalbutamol may increase blood pressure, so its use is contraindicated in patients with severe or uncontrolled hypertension. - **Severe Hypokalemia**: While beta-agonists can cause an increase in potassium levels, in patients with existing severe hypokalemia, the drug may exacerbate this condition and worsen muscle weakness or arrhythmias.
Levosalbutamol, like other bronchodilators, can cause a range of side effects. Most are mild, but some may require medical attention: - **Common Side Effects**: These include tremors, nervousness, and palpitations (a sensation of the heart racing or pounding). These are typically mild and transient but can be bothersome for some patients. - **Cardiovascular Effects**: Levosalbutamol can cause tachycardia (fast heart rate), increased blood pressure, or arrhythmias, particularly when used in high doses or in patients with pre-existing heart conditions. If these symptoms are severe or persistent, the drug should be discontinued, and an alternative treatment should be considered. - **Musculoskeletal**: Muscle cramps or weakness can occur, especially in patients who experience significant hypokalemia as a side effect of the drug. - **Respiratory Issues**: Paradoxical bronchospasm, although rare, is a serious side effect that can occur after using levosalbutamol. Symptoms of paradoxical bronchospasm include increased wheezing, shortness of breath, or tightness in the chest. If this occurs, the medication should be discontinued, and emergency medical help should be sought. - **Hypokalemia**: Levosalbutamol may lower potassium levels in the blood, which could lead to muscle weakness, fatigue, or heart arrhythmias. This is more likely when used at higher doses or with other drugs that cause potassium depletion. - **Hypersensitivity Reactions**: Though rare, allergic reactions to levosalbutamol can occur, leading to symptoms such as swelling of the face, lips, or tongue, rash, or severe difficulty breathing. Anaphylaxis is a medical emergency and requires immediate cessation of the drug and intervention.
3
Levosalbutamol is a selective beta-2 adrenergic agonist that exerts its therapeutic effects by stimulating the beta-2 receptors found on smooth muscle cells in the lungs. This results in: - **Bronchodilation**: Activation of beta-2 receptors leads to the relaxation of bronchial smooth muscle, which opens the airways and reduces airway resistance. This helps alleviate symptoms of bronchospasm, such as wheezing, cough, and shortness of breath. - **Selectivity**: Levosalbutamol is a racemic mixture of the R-isomer of albuterol, which is thought to be responsible for the majority of its bronchodilatory effects. By being more selective for beta-2 receptors, it has fewer side effects related to beta-1 stimulation (such as tachycardia) compared to racemic albuterol. - **Fast-Acting**: Levosalbutamol is rapidly absorbed into the lungs after inhalation and works within minutes to relieve acute symptoms. This makes it a valuable option for patients needing fast relief from bronchospasm. - **Longer Duration of Action**: Levosalbutamol has a slightly longer duration of action compared to racemic albuterol, providing extended bronchodilation and reducing the need for frequent dosing in some patients.
Levosalbutamol can interact with several medications, particularly those that affect the cardiovascular or respiratory system. Key interactions include: - **Beta-Blockers**: The use of levosalbutamol with beta-blockers can counteract the bronchodilatory effect of the drug. Non-selective beta-blockers, such as propranolol, should be avoided in patients using levosalbutamol, as they may precipitate bronchospasm. If a beta-blocker is necessary, a cardioselective one should be used with caution. - **Other Beta-Agonists**: Combining levosalbutamol with other beta-agonists (e.g., albuterol) can lead to additive effects, increasing the risk of tachycardia, tremors, and other side effects. Care should be taken not to exceed the recommended dosage. - **Diuretics**: Diuretics, particularly those that promote potassium excretion (such as furosemide), can enhance the potassium-lowering effects of levosalbutamol. This can increase the risk of hypokalemia, leading to arrhythmias and muscle cramps. Monitoring potassium levels is advised. - **MAO Inhibitors and Tricyclic Antidepressants (TCAs)**: These medications increase the risk of cardiovascular side effects when combined with levosalbutamol, including hypertension and tachycardia. Patients using these drugs should avoid levosalbutamol or use it under strict medical supervision. - **Corticosteroids**: When used together with corticosteroids, levosalbutamol can increase the risk of systemic side effects such as increased glucose levels and adrenal suppression, especially with long-term use.
Information not available
For adults, the typical dosing regimen for levosalbutamol depends on the severity of the symptoms and the condition being treated: - **Acute Bronchospasm**: 1-2 inhalations (90 mcg per puff) every 4-6 hours as needed. For some patients, up to 3 inhalations may be required per dose, depending on the severity of the symptoms. - **Exercise-Induced Bronchospasm**: 2 inhalations 15 minutes before exercise to prevent bronchospasm triggered by physical activity. - **Chronic Management of Asthma/COPD**: Levosalbutamol may be used as a rescue inhaler, but for chronic management, a combination with inhaled corticosteroids or other long-acting bronchodilators is recommended.
For children aged 4 years and older, the typical dose is: - **Acute Bronchospasm**: 1-2 inhalations every 4-6 hours as needed. The maximum daily dose should not exceed 12 inhalations. Levosalbutamol is not recommended for children under 4 years old unless specifically prescribed by a healthcare provider. For children under 12 years old, a dose reduction may be necessary based on the severity of their symptoms and their overall health condition. For pediatric dosing and long-term use, it's crucial to follow a healthcare provider's guidance to minimize the risk of side effects and ensure proper symptom management.
There are no specific renal dose adjustments required for levosalbutamol when used in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, care should be taken, as they may have an increased risk of side effects. Monitoring for adverse reactions is recommended.
Information not available